Historical Valuation
Pulmatrix Inc (PULM) is now in the Undervalued zone, suggesting that its current forward PS ratio of 1.18 is considered Undervalued compared with the five-year average of -1.17. The fair price of Pulmatrix Inc (PULM) is between 4.08 to 6.60 according to relative valuation methord. Compared to the current price of 2.35 USD , Pulmatrix Inc is Undervalued By 42.35%.
Relative Value
Fair Zone
4.08-6.60
Current Price：2.35
42.35%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Pulmatrix Inc (PULM) has a current Price-to-Book (P/B) ratio of 1.74. Compared to its 3-year average P/B ratio of 1.40 , the current P/B ratio is approximately 24.73% higher. Relative to its 5-year average P/B ratio of 1.17, the current P/B ratio is about 49.15% higher. Pulmatrix Inc (PULM) has a Forward Free Cash Flow (FCF) yield of approximately -72.55%. Compared to its 3-year average FCF yield of -144.44%, the current FCF yield is approximately -49.78% lower. Relative to its 5-year average FCF yield of -118.36% , the current FCF yield is about -38.71% lower.
P/B
Median3y
1.40
Median5y
1.17
FCF Yield
Median3y
-144.44
Median5y
-118.36
Competitors Valuation Multiple
AI Analysis for PULM
The average P/S ratio for PULM competitors is 0.95, providing a benchmark for relative valuation. Pulmatrix Inc Corp (PULM.O) exhibits a P/S ratio of 1.18, which is 24.47% above the industry average. Given its robust revenue growth of -100.00%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for PULM
1Y
3Y
5Y
Market capitalization of PULM increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of PULM in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is PULM currently overvalued or undervalued?
Pulmatrix Inc (PULM) is now in the Undervalued zone, suggesting that its current forward PS ratio of 1.18 is considered Undervalued compared with the five-year average of -1.17. The fair price of Pulmatrix Inc (PULM) is between 4.08 to 6.60 according to relative valuation methord. Compared to the current price of 2.35 USD , Pulmatrix Inc is Undervalued By 42.35% .
What is Pulmatrix Inc (PULM) fair value?
PULM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Pulmatrix Inc (PULM) is between 4.08 to 6.60 according to relative valuation methord.
How does PULM's valuation metrics compare to the industry average?
The average P/S ratio for PULM's competitors is 0.95, providing a benchmark for relative valuation. Pulmatrix Inc Corp (PULM) exhibits a P/S ratio of 1.18, which is 24.47% above the industry average. Given its robust revenue growth of -100.00%, this premium appears unsustainable.
What is the current P/B ratio for Pulmatrix Inc (PULM) as of Jan 09 2026?
As of Jan 09 2026, Pulmatrix Inc (PULM) has a P/B ratio of 1.74. This indicates that the market values PULM at 1.74 times its book value.
What is the current FCF Yield for Pulmatrix Inc (PULM) as of Jan 09 2026?
As of Jan 09 2026, Pulmatrix Inc (PULM) has a FCF Yield of -72.55%. This means that for every dollar of Pulmatrix Inc’s market capitalization, the company generates -72.55 cents in free cash flow.
What is the current Forward P/E ratio for Pulmatrix Inc (PULM) as of Jan 09 2026?
As of Jan 09 2026, Pulmatrix Inc (PULM) has a Forward P/E ratio of -0.46. This means the market is willing to pay $-0.46 for every dollar of Pulmatrix Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Pulmatrix Inc (PULM) as of Jan 09 2026?
As of Jan 09 2026, Pulmatrix Inc (PULM) has a Forward P/S ratio of 1.18. This means the market is valuing PULM at $1.18 for every dollar of expected revenue over the next 12 months.